BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $920,400 | +102.1% | 130,000 | +100.9% | 0.00% | +33.3% |
| Q2 2023 | $455,488 | -35.7% | 64,700 | -23.9% | 0.00% | 0.0% |
| Q1 2023 | $708,900 | +147.0% | 85,000 | +240.0% | 0.00% | 0.0% |
| Q4 2022 | $287,000 | -74.8% | 25,000 | -82.1% | 0.00% | -80.0% |
| Q1 2019 | $1,140,000 | +8.7% | 140,000 | +7.7% | 0.02% | +7.1% |
| Q4 2018 | $1,049,000 | -37.5% | 130,000 | -40.9% | 0.01% | -33.3% |
| Q3 2018 | $1,679,000 | -2.3% | 220,000 | -26.7% | 0.02% | -12.5% |
| Q2 2018 | $1,719,000 | -35.6% | 300,000 | -46.4% | 0.02% | -56.4% |
| Q1 2018 | $2,671,000 | – | 560,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |